JP2004210715A5 - - Google Patents

Download PDF

Info

Publication number
JP2004210715A5
JP2004210715A5 JP2002382121A JP2002382121A JP2004210715A5 JP 2004210715 A5 JP2004210715 A5 JP 2004210715A5 JP 2002382121 A JP2002382121 A JP 2002382121A JP 2002382121 A JP2002382121 A JP 2002382121A JP 2004210715 A5 JP2004210715 A5 JP 2004210715A5
Authority
JP
Japan
Prior art keywords
osteoclast formation
formation inhibitor
sulfated glycosaminoglycan
inhibitor according
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002382121A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004210715A (ja
JP4567942B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2002382121A priority Critical patent/JP4567942B2/ja
Priority claimed from JP2002382121A external-priority patent/JP4567942B2/ja
Publication of JP2004210715A publication Critical patent/JP2004210715A/ja
Publication of JP2004210715A5 publication Critical patent/JP2004210715A5/ja
Application granted granted Critical
Publication of JP4567942B2 publication Critical patent/JP4567942B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002382121A 2002-12-27 2002-12-27 破骨細胞形成抑制剤 Expired - Fee Related JP4567942B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002382121A JP4567942B2 (ja) 2002-12-27 2002-12-27 破骨細胞形成抑制剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002382121A JP4567942B2 (ja) 2002-12-27 2002-12-27 破骨細胞形成抑制剤

Publications (3)

Publication Number Publication Date
JP2004210715A JP2004210715A (ja) 2004-07-29
JP2004210715A5 true JP2004210715A5 (cg-RX-API-DMAC7.html) 2006-02-09
JP4567942B2 JP4567942B2 (ja) 2010-10-27

Family

ID=32817794

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002382121A Expired - Fee Related JP4567942B2 (ja) 2002-12-27 2002-12-27 破骨細胞形成抑制剤

Country Status (1)

Country Link
JP (1) JP4567942B2 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401069D0 (sv) * 2004-04-26 2004-04-26 Anamar Medical Ab Use of Compounds for the Treatment of Diseases and Conditions
WO2006068146A1 (ja) * 2004-12-20 2006-06-29 Seikagaku Corporation 新規コンドロイチン硫酸画分
WO2006098332A1 (ja) * 2005-03-14 2006-09-21 Seikagaku Corporation 硬組織形成促進剤
JP5051999B2 (ja) * 2005-11-17 2012-10-17 国立大学法人名古屋大学 炎症性骨・軟骨疾患の処置剤
JP2007224286A (ja) * 2006-01-25 2007-09-06 Tottori Univ 生体組織からの多糖類の取得方法
JP5099617B2 (ja) * 2006-03-16 2012-12-19 国立大学法人東京農工大学 歯周病予防・治療剤
JP5063940B2 (ja) * 2006-06-20 2012-10-31 生化学工業株式会社 コンドロイチン硫酸・鉄コロイド製剤及びその製造方法
JPWO2008102568A1 (ja) * 2007-02-22 2010-05-27 株式会社Pgリサーチ 骨軟骨形成促進剤
SG181615A1 (en) * 2009-12-09 2012-07-30 Agency Science Tech & Res Glycosaminoglycan mixtures
RS58293B1 (sr) * 2011-05-12 2019-03-29 Gnosis Spa Biotehnološki sulfatisani hondroitin sulfat na poziciji 4 ili 6 na istom polisaharidnom lancu, i postupak za njegovu pripremu
CN105924544B (zh) * 2016-05-16 2018-03-09 山东大学 一种高硫酸化硫酸软骨素及其制备方法与应用
JP7673944B2 (ja) * 2020-12-23 2025-05-09 国立大学法人東海国立大学機構 破骨細胞増殖性疾患の予防又は治療剤
JPWO2024225380A1 (cg-RX-API-DMAC7.html) * 2023-04-25 2024-10-31

Similar Documents

Publication Publication Date Title
BR0315149A (pt) Misturas de polissacarìdeos derivados de heparina, sua preparação e as composições farmacêuticas que as contêm
NZ624749A (en) A sulfated polysaccharide compound and the preparation and use thereof
JP2011513034A5 (cg-RX-API-DMAC7.html)
WO2005019256A3 (en) Muteins of tear lipocalin
WO2008015239A3 (en) Muteins of tear lipocalin and methods for obtaining the same
WO2002023190A8 (en) Methods and products related to low molecular weight heparin
JP2016523535A5 (cg-RX-API-DMAC7.html)
Przybylski et al. HABA-based ionic liquid matrices for UV-MALDI-MS analysis of heparin and heparan sulfate oligosaccharides
Nishi et al. Enantiomer separation by capillary electrophoresis utilizing noncyclic mono-, oligo-and polysaccharides as chiral selectors
WO2004029095A3 (en) Cohesive coprecipitates of sulfated polysaccharide and fibrillar protein and use thereof
KR102007554B1 (ko) N-탈황화된 글리코스아미노글리칸 유도체 및 약물로서의 용도
EP1659143A4 (en) HYDROGEL SENSITIVE AT TEMPERATURE
JP2008515832A5 (cg-RX-API-DMAC7.html)
DE60208528D1 (de) Hochsulfatierte derivate von k5-polysacchariden und ihre herstellung
PL375088A1 (en) Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation
DE69813216T2 (de) Oligosaccharidemischungen mit antithrombotischer wirkung
JP2004210715A (ja) 破骨細胞形成抑制剤
EP3082869B1 (en) Combination of glycosaminoglycans and cyclodextrins
UA89356C2 (ru) Смесь олигосахаридов, которые являются производными гепаринина, способ ее получения и фармацевтическая композиция, которая их содержит
ATE388169T1 (de) Niedermolekulare polysaccharide mit antithrombotischer wirkung
TW200745154A (en) Oligosaccharides derived from fucoidan
RU2003110022A (ru) Экзогенные биологически активные конъюгирующие вещества
JP2006298791A (ja) グリコサミノグリカン又はその塩を含む経口投与用医薬品、健康食品又は栄養薬品組成物。
Maaroufi et al. Effect of oversulfated dermatan sulfate derivatives on platelet aggregation
SK277976B6 (en) Network copper derivative of hyaluron acid and method of its preparation